Vimarsana
Biggest News Aggregation in the World

Page 2 - Markus Hoffmann News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Markus Hoffmann. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Markus Hoffmann Today - Breaking & Trending Today

'Eris' Covid Variant Better At Escaping Immunity Than Other Strains: Lancet Study - Vimarsana News

'Eris' Covid Variant Better At Escaping Immunity Than Other Strains: Lancet Study

The study found that that EG.5.1 is not more infectious than its predecessors, meaning it cannot infect host cells more effectively

Source: ndtv.com
MSM Warns That The "Eris" Variant is "On The Rise" - Vimarsana News

MSM Warns That The "Eris" Variant is "On The Rise"

The Eris variant, which is different than "Pirola" (the current variant the mainstream media is fear-mongering over), is "on the rise." Eris had been classified as a variant of interest by the tyrannical agency, the World Health Organization (WHO.)

Lancet study decodes what's behind EG.5.1's rapid spread - Vimarsana News

Lancet study decodes what's behind EG.5.1's rapid spread

The highly transmissible Covid sub-varaint EG.5, dubbed as Eris, isspreading rapidly across the globe because of its ability to escape from antibodies, finds a study.Since May 2023, the EG.5 lineage of SARS-CoV-2, known as Eris, has been ...

'Eris' Covid Variant Can Escape Immunity Better Than Other Strains: Lancet Study - Vimarsana News

'Eris' Covid Variant Can Escape Immunity Better Than Other Strains: Lancet Study

The EG.5.1 variant of SARS-CoV-2 can escape neutralising antibodies better than other currently circulating strains, giving it an advantage in infecting vaccinated or previously infected people, according to a study published in

Source: ndtv.com
Study finds Eris Covid variant better at escaping immunity than other strains - Vimarsana News

Study finds Eris Covid variant better at escaping immunity than other strains

The Lancet study shows EG.5.1 variant evades antibodies moderately but lacks increased infectivity, posing a limited challenge to immunity from vaccination or prior infection.